Tumor cell clearance reimagined.
Our mission is to discover, translate, and deliver pioneering curative cell therapies that incorporate multiple forms of tumor clearance into single T cells.
CERs explained
Our technology aims to integrate anti-tumor capabilities of both the innate and adaptive immune systems into a single T cell.
› Exploiting a Natural Immune ProcessThe CER platform
We are advancing a CER T-cell platform that potentially offers novel approaches for the treatment of both hematologic malignancies and solid tumors.
› Therapeutic Potential of Our PlatformJoin the quest
Our culture is mission-and innovation-driven towards bringing improved treatment options to patients. We are looking for talented and motivated individuals to join us in our quest.
› Careers at CERoA differentiated mechanism of action for solid tumors
Check out pre-clinical data on CER T cell activity in NSCLC presented at the Society of Immunotherapy of Cancer (SITC) annual meeting.
› Read articleNews and events
May 15, 2024
CERo Therapeutics, Inc. Provides Corporate Update for ShareholdersApr 30, 2024
CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing AttributesMar 07, 2024
CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients